
EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …

The FDA has revealed that two of its prominent Directors are set to retire from the agency, leaving three of …

Alexion has lifted the curtain on new data for its C5 complement inhibitor ALXN1210, demonstrating its non-inferiority to another of …

Following a non-profit report that higher rates of death were associated with Acadia Pharmaceuticals’ Nuplazid, Scott Gottlieb has made comments …

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …

MSD has taken a legal hit after a US appeals court upheld a ruling that the pharma giant had illicitly …

The Life Sciences Industrial Strategy was supposed to forge a path forward for the industry, despite pressures from Brexit, to …

A Cancer Research UK-funded study undertaken by the University of Glasgow has revealed that representation and coverage of cancer patients …

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …

Researchers at St Louis Washington University School of Medicine have uncovered a promising extra application of a particular Janus Kinase …

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …

There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …